TrialMedical oncology (Northwood, London, England)2014

Safety and efficacy of second-line treatment with folinic acid, 5-fluorouracil and irinotecan (FOLFIRI) in combination of panitumumab and bevacizumab for patients with metastatic colorectal cancer.

Song Xie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.